HONOR, LEARN, ACT – Session 1

This broadcast focuses on those affected by GBM across the community: patients, care partners, family, medical providers, and researchers. Throughout the program, you will hear from leading researchers about the latest innovations in GBM treatment, patient and care partner experiences, and clinicians who treat patients every day. Learn about the GBM Awareness Day Resolution and what action steps you can take to help create change for GBM patients and families.

LEARN MORE WATCH NOW

Skip to segment:

• KIRK TANNER, PhD
  Chief Scientific Officer National Brain Tumor Society
• DUANE MITCHELL, PhD
  Director, University of Florida Brain Tumor Immunotherapy Program, Co-Director, Preston A. Wells Jr. Center for Brain Tumor Therapy
• ROBERT CAVALIERE, MD
  Neuro-Oncologist, Baptist MD Anderson Cancer Center
• PATRICK REGIS, APRN
  Baptist MD Anderson Cancer Center
• DAVID LOUIS, MD
  Pathologist-in-Chief, Massachusetts General Hospital, Benjamin Castleman Professor of Pathology, Harvard Medical School
• RANJIT BINDRA, MD, PhD
  Co-Director, Yale Brain Tumor Center at Smilow Cancer Hospital Professor of Therapeutic Radiology
• DAVID CACHIA, MD
  Neuro-Oncologist Associate Professor, Medical University of South Carolina
• SCOTT LINDHORST, MD
  Neuro-Oncologist Associate Professor, Medical University of South Carolina
• EDJAH NDOUM, MD
  Assistant Clinical Investigator National Institute Of Health, National Brain Tumor Society Board Member
• JACLYN GARCIA RN, CNRN
  Nurse Navigator, Ivy Brain Tumor Center Neurosurgical Oncology
• VERONICA DEROSA, RN, BA, CBC, RMT
  Oncology Nurse Case Coordinator Neuro-Oncology Team, Hyundai Cancer Institute, Children’s Hospital of Orange County

LEARN – Defeating GBM: A Virtual Town Hall

Moderated by New York Times Pulitzer Prize-winning investigative reporter Eric Lipton, the virtual town hall examined the state of GBM research – where we are, where we need to be, and what we need to get to cures. Town Hall guests include Adam Hayden, GBM patient and advocate; Dr. Ned Sharpless, Director of the National Cancer Institute (NCI); Dr. Richard Pazdur, Director of the FDA’s Oncology Center of Excellence (OCE); Dr. Susan Chang, Director of the Glioblastoma Precision Medicine Program, University of California, San Francisco; Dr. Patrick Wen, Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute; and David Arons, CEO of the National Brain Tumor Society.

LEARN MORE WATCH NOW

HONOR, LEARN, ACT – Session 2

Our program continues with additional stories and experiences that convey the current status of care for GBM, and what we can hope for in the future. There are many perspectives to share, and our broadcast features more patient and care partner experiences, research updates, and clinician viewpoints. We will outline what more you can do to raise awareness and we hope you will be inspired to take action.

LEARN MORE WATCH NOW

Skip to segment:

• JUSTIN T. JORDAN, MD, MPH, FAAN
  Clinical Director, Pappas Center for Neuro-Oncology Massachusetts General Hospital Assistant Professor of Neurology Harvard Medical School
• MEREDITH BUXTON
  Chief Executive Officer, Global Coalition for Adaptive Research
• AMY MAGUIRE, MS, CCC-SLP
  Speech Language Pathologist Massachusetts General Hospital
• JUSTIN LATHIA, PhD
  Associate Professor, Cleveland Clinic, Lerner Research Institute
• MARIELLA FILBIN, MD, PhD
  Physician, Dana-Farber Cancer Institute Assistant Professor of Pediatrics, Harvard Medical School
• JOSH ALLEN, PhD
  Chief Scientific Officer, Oncoceutics
• AKANKSHA SHARMA, MD
  Neuro-Oncologist Hospice/Palliative Medicine
• EVANTHIA GALANIS, MD
  Professor of Oncology Mayo Clinic, National Brain Tumor Society Board Member
• JAMES M. SNYDER, DO
  Neuro-Oncologist, Hermelin Brain Tumor Center Department of Neurosurgery Henry Ford Hospital